What is the market doing?
What the tape says about BMRN
BioMarin Pharmaceutical Inc. is +10% over the past year while the S&P 500 is +23%: 12 points behind the market.
+10%
1-year return · S&P 500 +23%
- vs 200-day average
- +15%
vs 200-day average · a clear uptrend
- RSI (14)
- 60
RSI (14) · neutral
- Below its 52-week high
- −6.6%
Below its 52-week high
Details›
- Last close2026-08-26
- $65.62
- 1 monthS&P 500 +3.7%
- +11%
- 1 yearS&P 500 +23%
- +10%
- 5 yearsS&P 500 +87%
- −15%
- vs 50-day average$60.41
- +8.6%
- 52-week high
- $70.23
- 52-week low
- $49.67
- Annualised volatility
- 36%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$3.2M
| Year | Return |
|---|---|
| 2026 (year to date) | +10% |
| 2025 | −9.6% |
| 2024 | −32% |
| 2023 | −6.8% |
| 2022 | +17% |
| 2021 | +0.75% |
| 2020 | +3.7% |
| 2019 | −0.70% |
| 2018 | −4.5% |
| 2017 | +7.6% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +1.0% |
| Feb | 10 | 4 of 10 | −1.2% |
| Mar | 10 | 1 of 10 | −3.2% |
| Apr | 10 | 5 of 10 | +0.28% |
| May | 10 | 3 of 10 | −1.6% |
| Jun | 10 | 8 of 10 | +5.0% |
| Jul | 11 | 7 of 11 | +3.1% |
| Aug | 11 | 7 of 11 | −1.1% |
| Sep | 10 | 1 of 10 | −6.0% |
| Oct | 10 | 3 of 10 | −3.4% |
| Nov | 10 | 10 of 10 | +7.3% |
| Dec | 10 | 7 of 10 | +2.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.